The Extracorporeal Life Support Organization Registry: update and perspectives
The Extracorporeal Life Support Organization Registry: update and perspectives
复制标题
DOI：
10.21037/acs.2018.11.03
复制
发表时间：
2019-01-01
影响因子：
3.1
通讯作者：
Barbaro, Ryan
中科院分区：
文献类型：
--
作者：
Lorusso, Roberto;Alexander, Peta;Barbaro, Ryan
自的体外生命支持组织登记处诞生以来，为了为体外生命支持用户提供有用的信息和基准，创建了收集有关难治性心脏或呼吸损害的体外生命支持的最相关信息。多年来，该注册中心不断发展，2018年实现了100,000多名患者，包括世界各地近500个ELSO中心。基于数据库分析的相关性和影响，以及对更先进和高质量临床研究的日益增长的需求，ELSO注册中心正在进行实质性的重新设计，这将允许并为ELSO成员和科学界提供一个增强的科学工具，以阐明ECLS环境的各个方面，包括趋势和疾病特定信息，以对我们自己的结果和结果与地区或全球结果进行基准比较，并为临床研究提供宝贵的数据来源。
From the birth of the Extracorporeal Life Support Organization (ELSO) Registry in 1989, collecting the most relevant information about extracorporeal life support (ECLS) for refractory cardiac or respiratory compromise, was created in order to provide useful information and benchmark for ECLS users. Throughout the years, the Registry has continuously developed, achieving in 2018 more than 100,000 patients included with almost 500 ELSO centers around the world. Based on the relevance and impact of database analysis, and due to the growing need for more advanced and high-quality clinical investigations, the ELSO Registry is under substantial re-engineering which will allow and provide the ELSO members and the scientific community an enhanced scientific tool to elucidate various aspects of the ECLS settings, including trends and disease-specific information, to perform benchmarking about our own results and outcomes as compared to regional or worldwide results, and to provide an invaluable source of data for clinical investigations.